Functional autoantibodies against G protein-coupled receptors in patients with persistent Long COVID 19 symptoms.
Zug, Switzerland, and Berlin, Germany, 19 April 2021
A new paper is published about Functional autoantibodies against G protein-coupled receptors in patients with persistent post COVID 19 symptoms. It can be downloaded from the publisher.
Highlights
- Sera from Long COVID syndrome patients contained functionally active autoantibodies targeting G protein-coupled receptors.
- Autoantibodies target β2- and α1-adrenoceptors, angiotensin II AT1-, muscarinic M2-, MAS-, nociceptin- and ETA-receptors.
- Included syndromes were of neurological and cardiological origin, or a combination of both.
- Such autoantibody patterns have previously been seen in COVID independent neurological deficits and cardiovascular disease.
